跳轉至內容
Merck
  • Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability.

Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability.

Human mutation (2014-09-11)
Sandra Donkervoort, Ying Hu, Tanya Stojkovic, Nicol C Voermans, A Reghan Foley, Meganne E Leach, Jahannaz Dastgir, Véronique Bolduc, Thomas Cullup, Alix de Becdelièvre, Lin Yang, Hai Su, Katherine Meilleur, Alice B Schindler, Erik-Jan Kamsteeg, Pascale Richard, Russell J Butterfield, Thomas L Winder, Thomas O Crawford, Robert B Weiss, Francesco Muntoni, Valérie Allamand, Carsten G Bönnemann
摘要

Collagen 6-related dystrophies and myopathies (COL6-RD) are a group of disorders that form a wide phenotypic spectrum, ranging from severe Ullrich congenital muscular dystrophy, intermediate phenotypes, to the milder Bethlem myopathy. Both inter- and intrafamilial variable expressivity are commonly observed. We present clinical, immunohistochemical, and genetic data on four COL6-RD families with marked intergenerational phenotypic heterogeneity. This variable expression seemingly masquerades as anticipation is due to parental mosaicism for a dominant mutation, with subsequent full inheritance and penetrance of the mutation in the heterozygous offspring. We also present an additional fifth simplex patient identified as a mosaic carrier. Parental mosaicism was confirmed in the four families through quantitative analysis of the ratio of mutant versus wild-type allele (COL6A1, COL6A2, and COL6A3) in genomic DNA from various tissues, including blood, dermal fibroblasts, and saliva. Consistent with somatic mosaicism, parental samples had lower ratios of mutant versus wild-type allele compared with the fully heterozygote offspring. However, there was notable variability of the mutant allele levels between tissues tested, ranging from 16% (saliva) to 43% (fibroblasts) in one mosaic father. This is the first report demonstrating mosaicism as a cause of intrafamilial/intergenerational variability of COL6-RD, and suggests that sporadic and parental mosaicism may be more common than previously suspected.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
盐酸, ACS reagent, 37%
Sigma-Aldrich
盐酸, ACS reagent, 37%
Sigma-Aldrich
氯化氢 溶液, 4.0 M in dioxane
Sigma-Aldrich
盐酸 溶液, 1.0 N, BioReagent, suitable for cell culture
Sigma-Aldrich
L -抗坏血酸, BioXtra, ≥99.0%, crystalline
Sigma-Aldrich
盐酸, 37 wt. % in H2O, 99.999% trace metals basis
Sigma-Aldrich
盐酸, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., fuming, ≥37%, APHA: ≤10
Sigma-Aldrich
盐酸, meets analytical specification of Ph. Eur., BP, NF, fuming, 36.5-38%
Sigma-Aldrich
盐酸, 36.5-38.0%, BioReagent, for molecular biology
Sigma-Aldrich
氯化氢 溶液, 2.0 M in diethyl ether
Sigma-Aldrich
L -抗坏血酸, powder, suitable for cell culture, γ-irradiated
Sigma-Aldrich
L -抗坏血酸, suitable for cell culture, suitable for plant cell culture, ≥98%
Supelco
盐酸 溶液, volumetric, 0.1 M HCl (0.1N), endotoxin free
Sigma-Aldrich
L -抗坏血酸, reagent grade, crystalline
Sigma-Aldrich
L -抗坏血酸, 99%
USP
抗坏血酸, United States Pharmacopeia (USP) Reference Standard
Supelco
L -抗坏血酸, analytical standard
Supelco
维生素C, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
氯化氢 溶液, 1.0 M in diethyl ether
Sigma-Aldrich
氯化氢, ReagentPlus®, ≥99%
Sigma-Aldrich
盐酸, puriss., 24.5-26.0%
Sigma-Aldrich
L -抗坏血酸, reagent grade
Sigma-Aldrich
L -抗坏血酸, ACS reagent, ≥99%
Sigma-Aldrich
L -抗坏血酸, meets USP testing specifications
Sigma-Aldrich
盐酸 溶液, ~6 M in H2O, for amino acid analysis
Sigma-Aldrich
氯化氢 溶液, 3 M in cyclopentyl methyl ether (CPME)
Sigma-Aldrich
L -抗坏血酸, FCC, FG
Sigma-Aldrich
盐酸 溶液, 32 wt. % in H2O, FCC
Sigma-Aldrich
L -抗坏血酸, BioUltra, ≥99.5% (RT)
Sigma-Aldrich
氯化氢 溶液, 1.0 M in acetic acid